BIT 2.22% 4.6¢ biotron limited

johnson & johnson

  1. 357 Posts.
    lightbulb Created with Sketch. 113
    This Wall St Journal article/video on Johnson&Johnson is really interesting...describing how the big pharma company is scouting out deals with small biotech companies.

    http://online.wsj.com/news/article_email/SB10001424052702304703804579384871050414310-lMyQjAxMTA0MDAwOTEwNDkyWj

    It raises hopes for all small aussie biotechs, but particularly for Biotron.

    Why? The article says Hepatitis C is one of the diseases where J&J is actively scouting small biotech companies to find prospective drugs.

    Oh yes, and CEO Michelle Miller is ex-J&J, so is Biotron board member Dr Susan Ponds, as is fellow board member Dr Dennis Wade.

    Nothing conclusive, of course, but food for thought

    GLTAH
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
0.001(2.22%)
Mkt cap ! $41.50M
Open High Low Value Volume
4.4¢ 4.7¢ 4.4¢ $31.64K 708.3K

Buyers (Bids)

No. Vol. Price($)
4 259000 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 17361 1
View Market Depth
Last trade - 14.10pm 21/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.